| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 22/01/21 | 07:00:07 | 22 Jan 2021 | Preclinical data on a new therapeutic target | RNS | |
| 21/01/21 | 07:00:02 | 21 Jan 2021 | Positive pre-clinical data for lead asset SFX-01 | RNS | |
| 19/01/21 | 07:00:04 | 19 Jan 2021 | Patient recruitment update in STAR-COVID 19 trial | RNS | |
| 23/12/20 | 14:05:56 | 23 Dec 2020 | Second Price Monitoring Extn | RNS | |
| 23/12/20 | 14:00:58 | 23 Dec 2020 | Price Monitoring Extension | RNS | |
| 10/12/20 | 07:00:06 | 10 Dec 2020 | Half-year Report | RNS | |
| 27/11/20 | 14:33:01 | 27 Nov 2020 | Holding(s) in Company | RNS | |
| 27/11/20 | 09:15:01 | 27 Nov 2020 | Holding(s) in Company | RNS | |
| 23/11/20 | 07:00:06 | 23 Nov 2020 | Recruitment of first patient in STAR trial | RNS | |
| 11/11/20 | 07:00:02 | 11 Nov 2020 | Comment on the COVID-19 vaccine announcement | RNS | |
| 06/11/20 | 09:25:05 | 6 Nov 2020 | Holding(s) in Company | RNS | |
| 29/10/20 | 11:55:49 | 29 Oct 2020 | Holding(s) in Company | RNS | |
| 29/10/20 | 09:09:25 | 29 Oct 2020 | Holding(s) in Company | RNS | |
| 26/10/20 | 15:00:05 | 26 Oct 2020 | Holding(s) in Company | RNS | |
| 23/10/20 | 07:00:04 | 23 Oct 2020 | All approvals received for STAR trial to commence | RNS | |
| 06/10/20 | 07:00:08 | 6 Oct 2020 | Grant of options | RNS | |
| 24/09/20 | 07:00:06 | 24 Sept 2020 | Appointment of Chief Executive Officer | RNS | |
| 15/09/20 | 07:00:04 | 15 Sept 2020 | Licence agreement with Juvenescence | RNS | |
| 18/08/20 | 15:30:07 | 18 Aug 2020 | Holding(s) in Company | RNS | |
| 18/08/20 | 15:25:06 | 18 Aug 2020 | Holding(s) in Company | RNS | |
| 14/08/20 | 16:41:05 | 14 Aug 2020 | Second Price Monitoring Extn | RNS | |
| 14/08/20 | 16:35:52 | 14 Aug 2020 | Price Monitoring Extension | RNS | |
| 05/08/20 | 16:41:30 | 5 Aug 2020 | Second Price Monitoring Extn | RNS | |
| 05/08/20 | 16:35:54 | 5 Aug 2020 | Price Monitoring Extension | RNS | |
| 31/07/20 | 15:40:21 | 31 Jul 2020 | Holding(s) in Company | RNS | |
| 24/07/20 | 09:47:45 | 24 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 17/07/20 | 12:05:34 | 17 Jul 2020 | Holding(s) in Company | RNS | |
| 17/07/20 | 12:02:43 | 17 Jul 2020 | Holding(s) in Company | RNS | |
| 16/07/20 | 14:52:46 | 16 Jul 2020 | Result of AGM | RNS | |
| 07/07/20 | 11:13:15 | 7 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 06/07/20 | 07:00:05 | 6 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 23/06/20 | 11:44:54 | 23 Jun 2020 | Holding(s) in Company | RNS | |
| 23/06/20 | 11:38:23 | 23 Jun 2020 | Holding(s) in Company | RNS | |
| 19/06/20 | 07:00:05 | 19 Jun 2020 | Notice of AGM | RNS | |
| 17/06/20 | 09:38:19 | 17 Jun 2020 | Holding(s) in Company | RNS | |
| 17/06/20 | 09:37:12 | 17 Jun 2020 | Holding(s) in Company | RNS | |
| 17/06/20 | 07:00:04 | 17 Jun 2020 | SFX-01 to be evaluated in COVID-19 trial | RNS | |
| 15/06/20 | 17:05:35 | 15 Jun 2020 | Holding(s) in Company | RNS | |
| 15/06/20 | 07:00:08 | 15 Jun 2020 | Final Results | RNS | |
| 08/06/20 | 07:00:08 | 8 Jun 2020 | Paper on SFX-01 in ER positive breast cancer | RNS | |
| 05/06/20 | 07:00:03 | 5 Jun 2020 | Notice of Results | RNS | |
| 15/05/20 | 12:30:05 | 15 May 2020 | Statement Re: Share Price Movement | RNS | |
| 30/04/20 | 07:00:08 | 30 Apr 2020 | Directorate Change | RNS | |
| 20/02/20 | 09:27:03 | 20 Feb 2020 | Holding(s) in Company | RNS | |
| 13/02/20 | 07:00:06 | 13 Feb 2020 | University of Rochester Collaboration | RNS | |
| 06/02/20 | 07:00:03 | 6 Feb 2020 | University of Manchester collaboration discovery | RNS | |
| 29/01/20 | 14:05:47 | 29 Jan 2020 | Second Price Monitoring Extn | RNS | |
| 29/01/20 | 14:00:22 | 29 Jan 2020 | Price Monitoring Extension | RNS | |
| 20/01/20 | 15:39:58 | 20 Jan 2020 | Holding(s) in Company | RNS | |
| 17/12/19 | 07:01:06 | 17 Dec 2019 | Investor presentation | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 22/01/21 | 07:00:07 | 22 Jan 2021 | Preclinical data on a new therapeutic target | RNS | |
| 21/01/21 | 07:00:02 | 21 Jan 2021 | Positive pre-clinical data for lead asset SFX-01 | RNS | |
| 19/01/21 | 07:00:04 | 19 Jan 2021 | Patient recruitment update in STAR-COVID 19 trial | RNS | |
| 23/12/20 | 14:05:56 | 23 Dec 2020 | Second Price Monitoring Extn | RNS | |
| 23/12/20 | 14:00:58 | 23 Dec 2020 | Price Monitoring Extension | RNS | |
| 10/12/20 | 07:00:06 | 10 Dec 2020 | Half-year Report | RNS | |
| 27/11/20 | 14:33:01 | 27 Nov 2020 | Holding(s) in Company | RNS | |
| 27/11/20 | 09:15:01 | 27 Nov 2020 | Holding(s) in Company | RNS | |
| 23/11/20 | 07:00:06 | 23 Nov 2020 | Recruitment of first patient in STAR trial | RNS | |
| 11/11/20 | 07:00:02 | 11 Nov 2020 | Comment on the COVID-19 vaccine announcement | RNS | |
| 06/11/20 | 09:25:05 | 6 Nov 2020 | Holding(s) in Company | RNS | |
| 29/10/20 | 11:55:49 | 29 Oct 2020 | Holding(s) in Company | RNS | |
| 29/10/20 | 09:09:25 | 29 Oct 2020 | Holding(s) in Company | RNS | |
| 26/10/20 | 15:00:05 | 26 Oct 2020 | Holding(s) in Company | RNS | |
| 23/10/20 | 07:00:04 | 23 Oct 2020 | All approvals received for STAR trial to commence | RNS | |
| 06/10/20 | 07:00:08 | 6 Oct 2020 | Grant of options | RNS | |
| 24/09/20 | 07:00:06 | 24 Sept 2020 | Appointment of Chief Executive Officer | RNS | |
| 15/09/20 | 07:00:04 | 15 Sept 2020 | Licence agreement with Juvenescence | RNS | |
| 18/08/20 | 15:30:07 | 18 Aug 2020 | Holding(s) in Company | RNS | |
| 18/08/20 | 15:25:06 | 18 Aug 2020 | Holding(s) in Company | RNS | |
| 14/08/20 | 16:41:05 | 14 Aug 2020 | Second Price Monitoring Extn | RNS | |
| 14/08/20 | 16:35:52 | 14 Aug 2020 | Price Monitoring Extension | RNS | |
| 05/08/20 | 16:41:30 | 5 Aug 2020 | Second Price Monitoring Extn | RNS | |
| 05/08/20 | 16:35:54 | 5 Aug 2020 | Price Monitoring Extension | RNS | |
| 31/07/20 | 15:40:21 | 31 Jul 2020 | Holding(s) in Company | RNS | |
| 24/07/20 | 09:47:45 | 24 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 17/07/20 | 12:05:34 | 17 Jul 2020 | Holding(s) in Company | RNS | |
| 17/07/20 | 12:02:43 | 17 Jul 2020 | Holding(s) in Company | RNS | |
| 16/07/20 | 14:52:46 | 16 Jul 2020 | Result of AGM | RNS | |
| 07/07/20 | 11:13:15 | 7 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 06/07/20 | 07:00:05 | 6 Jul 2020 | Share option exercise and issue of equity | RNS | |
| 23/06/20 | 11:44:54 | 23 Jun 2020 | Holding(s) in Company | RNS | |
| 23/06/20 | 11:38:23 | 23 Jun 2020 | Holding(s) in Company | RNS | |
| 19/06/20 | 07:00:05 | 19 Jun 2020 | Notice of AGM | RNS | |
| 17/06/20 | 09:38:19 | 17 Jun 2020 | Holding(s) in Company | RNS | |
| 17/06/20 | 09:37:12 | 17 Jun 2020 | Holding(s) in Company | RNS | |
| 17/06/20 | 07:00:04 | 17 Jun 2020 | SFX-01 to be evaluated in COVID-19 trial | RNS | |
| 15/06/20 | 17:05:35 | 15 Jun 2020 | Holding(s) in Company | RNS | |
| 15/06/20 | 07:00:08 | 15 Jun 2020 | Final Results | RNS | |
| 08/06/20 | 07:00:08 | 8 Jun 2020 | Paper on SFX-01 in ER positive breast cancer | RNS | |
| 05/06/20 | 07:00:03 | 5 Jun 2020 | Notice of Results | RNS | |
| 15/05/20 | 12:30:05 | 15 May 2020 | Statement Re: Share Price Movement | RNS | |
| 30/04/20 | 07:00:08 | 30 Apr 2020 | Directorate Change | RNS | |
| 20/02/20 | 09:27:03 | 20 Feb 2020 | Holding(s) in Company | RNS | |
| 13/02/20 | 07:00:06 | 13 Feb 2020 | University of Rochester Collaboration | RNS | |
| 06/02/20 | 07:00:03 | 6 Feb 2020 | University of Manchester collaboration discovery | RNS | |
| 29/01/20 | 14:05:47 | 29 Jan 2020 | Second Price Monitoring Extn | RNS | |
| 29/01/20 | 14:00:22 | 29 Jan 2020 | Price Monitoring Extension | RNS | |
| 20/01/20 | 15:39:58 | 20 Jan 2020 | Holding(s) in Company | RNS | |
| 17/12/19 | 07:01:06 | 17 Dec 2019 | Investor presentation | RNS |